These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Impact of SAMMPRIS on the future of intracranial atherosclerotic disease management: polling results from the ICAD symposium at the International Stroke Conference. Zaidat OO; Castonguay AC; Nguyen TN; Becker KJ; Derdeyn CP; Nelson PK; Amarenco P; Brott TG J Neurointerv Surg; 2014 Apr; 6(3):225-30. PubMed ID: 23563478 [TBL] [Abstract][Full Text] [Related]
7. Submaximal angioplasty for symptomatic intracranial atherosclerosis: a prospective Phase I study. Dumont TM; Sonig A; Mokin M; Eller JL; Sorkin GC; Snyder KV; Hopkins LN; Levy EI; Siddiqui AH J Neurosurg; 2016 Oct; 125(4):964-971. PubMed ID: 26745485 [TBL] [Abstract][Full Text] [Related]
8. Epidemiology, diagnosis and management of intracranial atherosclerotic disease. Jeng JS; Tang SC; Liu HM Expert Rev Cardiovasc Ther; 2010 Oct; 8(10):1423-32. PubMed ID: 20936929 [TBL] [Abstract][Full Text] [Related]
9. Revisiting angioplasty without stenting for symptomatic intracranial atherosclerotic stenosis after the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) study. Dumont TM; Kan P; Snyder KV; Hopkins LN; Siddiqui AH; Levy EI Neurosurgery; 2012 Dec; 71(6):1103-10. PubMed ID: 22986593 [TBL] [Abstract][Full Text] [Related]
11. Intracranial atherosclerotic disease: epidemiology, imaging and treatment. McTaggart RA; Jayaraman MV; Haas RA; Feldmann E Med Health R I; 2009 Dec; 92(12):412-4. PubMed ID: 20066829 [TBL] [Abstract][Full Text] [Related]
12. Current Advances in Endovascular Treatment of Intracranial Atherosclerotic Disease and Future Prospective. Jafari M; Nguyen TN; Ortega-Gutierrez S; Hussain MS; Hassan AE; Ikram A; Eliyas JK; Rodriguez GJ; Divani AA J Stroke Cerebrovasc Dis; 2021 Mar; 30(3):105556. PubMed ID: 33360252 [TBL] [Abstract][Full Text] [Related]
13. The 2023 Taiwan Stroke Society Guidelines for the management of patients with intracranial atherosclerotic disease. Lin CJ; Chung CP; Liao NC; Chen PL; Chi NF; Lai YJ; Tang CW; Wu CH; Chang FC; Luo CB; Fay LY; Lin CF; Chou CH; Lee TH; Lee JT; Jeng JS; Lee IH; J Chin Med Assoc; 2023 Aug; 86(8):697-714. PubMed ID: 37341526 [TBL] [Abstract][Full Text] [Related]
14. Is there a future for endovascular treatment of intracranial atherosclerotic disease after Stenting and Aggressive Medical Management for Preventing Recurrent Stroke and Intracranial Stenosis (SAMMPRIS)? Marks MP Stroke; 2012 Feb; 43(2):580-4. PubMed ID: 22246690 [TBL] [Abstract][Full Text] [Related]
15. Impact of WASID and Wingspan on the frequency of intracranial angioplasty and stenting at a high volume tertiary care hospital. Moskowitz SI; Kelly ME; Obuchowski N; Fiorella D J Neurointerv Surg; 2009 Dec; 1(2):165-7. PubMed ID: 21994290 [TBL] [Abstract][Full Text] [Related]
16. Current status of the management of symptomatic intracranial atherosclerotic disease: the rationale for a randomized trial of medical therapy and intracranial stenting. Fiorella D; Turan TN; Derdeyn CP; Chimowitz MI J Neurointerv Surg; 2009 Jul; 1(1):35-9. PubMed ID: 21994103 [TBL] [Abstract][Full Text] [Related]
18. Intracranial atherosclerosis update for neurointerventionalists. Alexander MJ; Yu W J Neurointerv Surg; 2024 Apr; 16(5):522-528. PubMed ID: 37295944 [TBL] [Abstract][Full Text] [Related]
19. Role of stenting for intracranial atherosclerosis in the post-SAMMPRIS era. Ding D; Starke RM; Crowley RW; Liu KC Biomed Res Int; 2013; 2013():304320. PubMed ID: 24350256 [TBL] [Abstract][Full Text] [Related]
20. Early aggressive medical management for patients with symptomatic intracranial stenosis. Nahab F; Kingston C; Frankel MR; Dion JE; Cawley CM; Mitchell B; Hammonds LP; Ayala L; Tong FC J Stroke Cerebrovasc Dis; 2013 Jan; 22(1):87-91. PubMed ID: 21795066 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]